Cargando…

Eligibility for drotrecogin alfa therapy on the basis of APACHE II score and organ failure

Detalles Bibliográficos
Autores principales:	Shulman, R, Bagga, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098343/ http://dx.doi.org/10.1186/cc3256

Ejemplares similares

Extended drotrecogin alfa (activated) therapy in patients with persistent requirement for vasopressor support after 96-hour infusion with commercial drotrecogin alfa (activated)
por: Dhainaut, J, et al.
Publicado: (2008)

Increasing microcirculation after drotrecogin alfa (activated)
por: Donati, A, et al.
Publicado: (2007)

Retrospective observational outcomes for drotrecogin alfa (activated)
por: Cameron, C, et al.
Publicado: (2007)

Early treatment with Drotrecogin alfa (activated) was associated with reduced hospital resource use in adult severe sepsis patients with an APACHE II score of 25 or greater at baseline: results from ENHANCE
por: Doig, C, et al.
Publicado: (2004)

Use of national guidelines for the introduction of Drotrecogin alfa (activated)
por: Mackenzie, S, et al.
Publicado: (2004)

Drotrecogin alfa: start early, ensure response, stop early!
por: Jog, S, et al.
Publicado: (2008)

Drotrecogin alfa (activated): a single-centre experience of 110 patients
por: Fletcher, S, et al.
Publicado: (2010)

Drotrecogin alfa (activated) does not impair platelet receptor expression in vitro
por: Schuerholz, T, et al.
Publicado: (2004)

Multicentre audit of the use of drotrecogin alfa (activated) in UK critical care units
por: Rowan, K, et al.
Publicado: (2007)

A large, single-centre UK registry of drotrecogin alfa-activated use
por: Macchiavello, L, et al.
Publicado: (2007)

Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
por: Beale, R, et al.
Publicado: (2007)

Audit of adherence to National Institute of Clinical Excellence guidelines for the use of drotrecogin alfa (activated)
por: Vedantham, R, et al.
Publicado: (2007)

Neuroaxial catheters following abdominal surgery and their impact on the use of Drotrecogin alfa (activated) in sepsis
por: Steel, A, et al.
Publicado: (2004)

Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation
por: Mirea, L, et al.
Publicado: (2011)

Drotrecogin alfa in sepsis: analysis of outcomes in a UK district general intensive care unit
por: Pathak, H, et al.
Publicado: (2004)

Outcomes and incidence of bleeding events associated with drotrecogin alfa: a single-centre experience of 440 patients
por: Boyle, A, et al.
Publicado: (2010)

Drotrecogin alfa in patients with severe sepsis: experience from a tertiary care center in North India
por: Chawla, R, et al.
Publicado: (2007)

Testing of anti-activated protein C antibodies in four drotrecogin alfa (activated) severe sepsis studies
por: Yan, S, et al.
Publicado: (2008)

Validation of the APACHE IV scoring system in patients with severe sepsis and comparison with the APACHE II system
por: Dahhan, T, et al.
Publicado: (2009)

Multimodal strategies to improve APACHE II score documentation
por: Donahoe, L, et al.
Publicado: (2005)

Three years experience with drotrecogin alfa (activated) protein C in severe sepsis and septic shock at Salmaniya Medical Complex, Bahrain
por: Mohamed, H, et al.
Publicado: (2007)

The safety profile of drotrecogin alfa (activated)
por: Fumagalli, Roberto, et al.
Publicado: (2007)

Disparity in outcome prediction between APACHE II, APACHE III and APACHE IV
por: Haddad, Z, et al.
Publicado: (2008)

Prediction of mortality of APACHE-II and APACHE-III scores in patients admitted to the intensive care unit (ICU) for intoxication
por: Banderas-Bravo, E, et al.
Publicado: (2015)

APACHE II score may predict mortality in burns patients
por: Martynoga, R, et al.
Publicado: (2009)

Inter-rater reliability of APACHE II scores in the medical ICU
por: Hu, X, et al.
Publicado: (2009)

Canadian ENHANCE data support the efficacy and safety of drotrecogin alfa (activated) despite higher disease severity than the global ENHANCE population
por: Hall, R, et al.
Publicado: (2005)

Validation of logistic organ dysfunction score prediction compared with APACHE II score prediction hospital outcome in Thai patients
por: Khwannimit, B
Publicado: (2007)

Early treatment with Drotrecogin alfa (activated) was associated with reduced hospital resource use in adult severe sepsis patients with two or more organ dysfunctions at baseline: results from ENHANCE
por: Vincent, J, et al.
Publicado: (2004)

Scoring systems (APACHE II and Simplified Acute Physiology Score II) for predicting outcome in status asthmaticus
por: Hachimi, A, et al.
Publicado: (2009)

Correlation between ffp transfusion and apache ii score in icu patients
por: Vakalos, A, et al.
Publicado: (2015)

Practical aspects of treatment with drotrecogin alfa (activated)
por: Camporota, Luigi, et al.
Publicado: (2007)

Introduction: severe sepsis and drotrecogin alfa (activated)
por: Artigas, Antonio, et al.
Publicado: (2007)

The efficacy of Drotrecogin alfa (activated) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
por: Vincent, J, et al.
Publicado: (2004)

Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
por: Vincent, J, et al.
Publicado: (2004)

Are APACHE II scores better predictors of mortality than routine laboratory values?
por: Baykara, Z, et al.
Publicado: (2013)

Serum levels of presepsin reffects the APACHE II and SOFA scores in patients with sepsis
por: Sato, R, et al.
Publicado: (2013)

Low APACHE II and ASA score predicts survival in patients with perforated peptic ulcer
por: Buck, David Levarett, et al.
Publicado: (2012)

APACHE II and SOFA scores for intensive care and hospital outcome prediction in oncologic patients
por: Forte, DN, et al.
Publicado: (2007)

SAPS 2 is a better score than APACHE II to predict mortality in the ICU
por: Nobre, G, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_n00l665bfchk783k0kpfrn52od